Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Contineum Therapeutics (CTNM) EBT Margin (2023)

Contineum Therapeutics (CTNM) has 1 years of EBT Margin data on record, last reported at 84.6% in Q2 2023.

  • For Q2 2023, EBT Margin changed N/A year-over-year to 84.6%; the TTM value through Mar 2024 reached 39.15%, changed N/A, while the annual FY2023 figure was 46.34%, N/A changed from the prior year.
  • EBT Margin reached 84.6% in Q2 2023 per CTNM's latest filing, down from 5243.48% in the prior quarter.
  • Across five years, EBT Margin topped out at 5243.48% in Q1 2023 and bottomed at 84.6% in Q2 2023.